Vetsys Pharmaceutical
Vetsys Pharmaceutical
The Commonwealth of The Bahamas, while primarily known for its service-based economy, maintains a strategic and resilient livestock sector across the Family Islands. Mastitis management remains the single most significant health challenge for small-scale dairy producers and communal livestock farmers in regions like Andros and Eleuthera. As a premier Intramammary Infusions Manufacturer, we recognize the unique environmental pressures—high humidity and tropical temperatures—that accelerate bacterial growth in bovine mammary tissues.
Currently, the Bahamian agricultural market relies heavily on high-quality imports for veterinary pharmacology. The "Department of Agriculture" in Nassau emphasizes biosecurity and the reduction of antibiotic resistance. Our supply chain bridge from China to Freeport and Nassau provides Bahamian farmers with access to 4th generation cephalosporins (Cefquinome Sulfate) that are often cost-prohibitive when sourced through traditional North American middlemen.
Sourcing from a specialized Chinese factory like Zhengzhou Vetsys Pharmaceutical Co., Ltd. offers unparalleled "Information Gain" for Bahamian distributors. We don't just supply products; we provide a technological ecosystem. With our registered capital of 30 million RMB and GMP-certified facilities, we ensure that every syringe of Intramammary Infusion meets the rigorous standards required for entry into Caribbean markets.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry. The facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health.
In the Bahamas, mastitis is frequently caused by environmental pathogens like Streptococcus uberis and Escherichia coli. Our Intramammary Infusions, specifically those containing Sulbactam Sodium and Prednisolone, provide a dual-action approach. Sulbactam acts as a beta-lactamase inhibitor, preventing bacterial resistance, while Prednisolone reduces the acute inflammation of the udder, allowing the animal to return to production faster.
Essential for Bahamian cattle during the non-lactating period to treat existing infections and prevent new ones. Our Cefquinome Sulfate formulas offer a long-acting protective barrier.
Fast-acting formulas with short milk-withdrawal periods, crucial for maintain cash flow in small-scale Bahamian dairy operations.
Vetsys is committed to the "One Health" approach. As the Bahamas moves towards more sustainable agricultural practices, our research into green technologies ensures that our drug residues are minimized, protecting the delicate Bahamian ecosystem and coastal water quality.
A: Typically, sea freight takes 35-45 days. For urgent veterinary needs, air freight options are available reaching Lynden Pindling International Airport within 7-10 days.
A: Yes, our products are manufactured under international GMP standards and we provide all necessary COA (Certificate of Analysis) and dossiers for local registration.
A: Absolutely. Our R&D institute can collaborate with local Bahamian veterinarians to provide customized concentrations of Ampicillin or Cloxacillin.
